Oxycodone: Clinical Trials

390 trials of Oxycodone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

259 completed, 39 unknown, 29 terminated, 25 recruiting. 132 Phase 4, 69 Phase 1, 67 Phase 3, 48 Not applicable, 48 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 4132Completed 81, Unknown 15, Terminated 10, Recruiting 8, Active not recruiting 4, Enrolling by invitation 4, Not yet recruiting 4, Withdrawn 4, Suspended 2
Phase 169Completed 60, Recruiting 3, Terminated 3, Unknown 3
Phase 367Completed 46, Unknown 8, Terminated 4, Withdrawn 4, Recruiting 3, Not yet recruiting 2
Not applicable48Completed 21, Unknown 9, Terminated 5, Not yet recruiting 4, Withdrawn 4, Recruiting 3, Active not recruiting 1, Suspended 1
Phase 248Completed 30, Terminated 8, Recruiting 3, Active not recruiting 2, Not yet recruiting 2, Unknown 2, Withdrawn 1
Early Phase 114Completed 8, Recruiting 3, Terminated 2, Unknown 1

Follow Oxycodone: new trials by email Literature Review of Oxycodone trials Research Report on Oxycodone

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
3D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer Pain
3D1002 (50 mg)(Phase IIa), 3D1002 (100 mg)(Phase IIa), 3D1002 (150 mg)(Phase IIa) - Cancer Pain
Phase 2Not yet recruiting3D Medicines1772026-12-012026-03-11
Suzetrigine for Opioid-Sparing Postoperative Analgesia Following Transvaginal Pelvic Reconstructive Surgery
Suzetrigine, Opioid Analgesics (Tramadol or Oxycodone), Scheduled Acetaminophen and Ibuprofen - Pelvic Organ Prolapse (POP), Stress Urinary Incontinence (SUI)
Phase 4Not yet recruitingUniversity of California, Los Angeles1202026-11-012026-09-15
Suzetrigine in Tonsillectomy for Opioid-sparing Pain Management
Suzetrigine, Acetaminophen, oxycodone - Tonsillectomy, Pharyngoplasty
Phase 4Not yet recruitingStanford University582026-11-012026-09-16
Examining Analgesic Synergy and Efficacy in Trauma Care
Buprenorphine, Oxycodone - Opioid Use Disorder
Phase 4Not yet recruitingWake Forest University Health Sciences2822026-10-012026-08-28
An Artificial Intelligence Driven Approach to Optimize Patient Selection for a Transitional Pain Service
TPS-Select, Pharmacologic Pain Management, Interventional Pain Procedures - Postsurgical Pain Management, Postsurgical Pain, Chronic
Phase 3Not yet recruitingUniversity of California, San Francisco4742026-10-012026-10-09
Post-Vasectomy Pain Study
Acetaminophen, ibuprofen, oxycodone - Vasectomy, NSAIDs
Phase 1RecruitingColumbia University2002026-09-102026-09-24
Evaluation of the Safety and Effects of Psychoactive Substances in People With Past Opioid Use
Placebo, Oxycodone HCl, Kratom 8g - Opioid Use, Substance Use Disorders
Phase 1RecruitingChristopher D. Verrico722026-09-012026-09-28
Abuse Potential of Gabapentin Taken Orally Concomitantly With Oxycodone Hydrochloride in Healthy, Non-Drug-Dependent, Recreational Opioid Users
Placebo, Oxycodone 20mg, gabapentin 600 mg - Healthy
Phase 4RecruitingViatris Inc.602026-08-032026-10-15
Pilot Randomized Control Trial Comparing Oral Ketamine and Oral Oxycodone for Pain Control in Emergency Department Patients
oral ketamine, oxycodone - Pain Management
Phase 2 / Phase 3Not yet recruitingAlbany Medical College602026-06-242026-06-26
Effect of Liposomal Bupivacaine TAPB Combined With Oxycodone PCIA on Postoperative Gastrointestinal Recovery in Patients Undergoing Major Abdominal Surgery
ropivacaine hydrochloride, Liposomal bupivacaine (LB), Sufentanil citrate - Postoperative Pain, Postoperative Ileus
Not applicableRecruitingTianjin First Central Hospital1322026-06-162026-06-25
Opioid-Sparing Joint Replacement
Placebo, Oxycodone 5 mg, Multimodal Non-Opioid Analgesia - Pain Management, Opioid Consumption
Phase 3RecruitingEmory University1202026-03-192026-04-17
Comparison of the Efficacy and Safety of Intravenous Buprenorphine Administered Via PCA System Versus Oxycodone in the Management of Postoperative Pain After Video-Assisted Thoracoscopic Surgery
Group B (Buprenorphine), Group O (Oxycodone) - Acute Postoperative Pain, Chronic Postoperative Pain
Phase 4RecruitingMedical University of Silesia2002026-03-182026-09-25
Comparison of Suzetrigine and Oxycodone for Postoperative Pain After Primary Total Knee Arthroplasty
oral suzetrigine, oral Oxycodone - Osteoarthritis (OA) of the Knee
Phase 4Enrolling by invitationUniversity of Louisville1402026-02-092026-05-04
Efficacy And Safety Of Tramadol And Oxycodone Versus Oxycodone Monotherapy For Pain Control After Primary Total Knee And Total Hip Arthroplasty
Oxycodone, Tramadol and Oxycodone - Post Operative Pain
Phase 4Enrolling by invitationMayo Clinic5602026-02-022026-03-18
Non-Narcotic Pain Control After ACL Reconstruction
dispense of study drug, Ketorolac - ACL - Anterior Cruciate Ligament Rupture, ACL Injuries
Phase 2Active not recruitingThe Cleveland Clinic302025-07-152026-08-24
Analgesic Effect and Safety of Oliceridine and Oxycodone in Vitrectomy
Oliceridine, Oxycodone - Vitrectomy
Not applicableNot yet recruitingHenan Provincial People's Hospital1202025-07-012025-07-31
A Study on Oral and Intranasal Forms of Oxycodone in Healthy Volunteers Using Pharmacokinetic Modeling
Oxycodone IN, oxycodone - Physiologically Based Pharmacokinetic, Healthy Volunteers
Phase 1CompletedParc de Salut Mar82025-06-122026-05-06
Multimodal Pain Management After Wide Awake Local Anesthesia No Tourniquet Orthopedic Hand Surgery: A Randomized Control Trial
Oxycodone 5mg taken first, Acetaminophen, Naproxen Tablets, 500 mg - Pain Management
Not applicableNot yet recruitingUniversity of Puerto Rico1002025-05-012025-04-08
Opioid Drug Interaction Study
Alprazolam, Oxycodone, Placebo - Drug Interactions, Drug Kinetics
Phase 1 / Phase 2RecruitingShanna Babalonis, PhD252025-04-012026-05-14
Real World Study of Oxycodone/Naloxone Sustained-Release Tablets (Mimeixin) for Patients With Severe Cancer Pain
Oxycodone Hydrochloride and Naloxone Hydrochloride Sustained-release Tablets - Opioid-Induced Constipation, Pain Cancer
Phase 4Not yet recruitingHenan Cancer Hospital2032025-04-012025-03-27

Showing 20 of 390. Sign in to see all of them.

Conditions studied

Pain (84)  ·  Pain, Postoperative (77)  ·  Agnosia (41)  ·  Opioid-Related Disorders (24)  ·  Chronic Pain (20)  ·  Acute Pain (16)  ·  Cancer Pain (14)  ·  Neoplasms (13)  ·  Osteoarthritis (11)  ·  Constipation (10)  ·  Low Back Pain (10)  ·  Substance-Related Disorders (8)  ·  Back Pain (5)  ·  Neuralgia (5)  ·  Osteoarthritis, Knee (5)

Sponsors

Pfizer (13)  ·  Purdue Pharma LP (13)  ·  Pain Therapeutics (12)  ·  Mundipharma (China) Pharmaceutical Co. Ltd (9)  ·  Kuopio University Hospital (6)  ·  Mundipharma Korea Ltd (6)  ·  QRxPharma Inc. (6)  ·  Mallinckrodt (5)  ·  Mayo Clinic (5)  ·  Mundipharma Research GmbH & Co KG (5)  ·  New York State Psychiatric Institute (5)  ·  Rothman Institute Orthopaedics (5)  ·  Ensysce Biosciences (4)  ·  M.D. Anderson Cancer Center (4)  ·  Medical University of Lublin (4)

Countries

United States (221)  ·  China (23)  ·  Canada (13)  ·  South Korea (13)  ·  Finland (12)  ·  Poland (10)  ·  United Kingdom (10)  ·  Italy (9)  ·  Norway (8)  ·  Denmark (7)  ·  Netherlands (7)  ·  Belgium (6)  ·  Germany (6)  ·  Sweden (6)  ·  Israel (5)

Top investigators

Merja Kokki, MD, PhD (4)  ·  Patricia T. Richards, MD, Ph.D. (4)  ·  Herbert Neuman, MD (3)  ·  Ajay D Wasan, MD, MSc (2)  ·  Anurag Singh (2)  ·  Chi Hornik, PharmD (2)  ·  Christopher R. Longnecker,, M.D. (2)  ·  David H Chi, MD (2)  ·  Doo-Yeoun Cho, MD (2)  ·  Erol Onel (2)  ·  Eva-Corina Caragounis, MD (2)  ·  Hans Granhed, MD PhD (2)

Results publications

PMID 31456431, PMID 31849032, PMID 11877663, PMID 12351295, PMID 15151094, PMID 15791113, PMID 16215338, PMID 16616268, PMID 17581533, PMID 18582827, PMID 18654615, PMID 19155895, PMID 19195785, PMID 19331993, PMID 19338859, PMID 19380256, PMID 19445652, PMID 20079977, PMID 20173643, PMID 20384968, PMID 20890791, PMID 20974443, PMID 21102969, PMID 21231862, PMID 21937568, PMID 22008309, PMID 22179861, PMID 2221417, PMID 22260216, PMID 22524979, PMID 22717418, PMID 23221859, PMID 23340531, PMID 23379573, PMID 23508626, PMID 23545428, PMID 23577077, PMID 23707270, PMID 23709304, PMID 24156640, PMID 24353047, PMID 24595069, PMID 24614374, PMID 24682079, PMID 24916058, PMID 24949994, PMID 24985410, PMID 25265132, PMID 25531960, PMID 25993547

NIH funding

2009 (3), 2008 (2), 2015 (2), 2004 (1), 2017 (1), 2019 (1), 2023 (1), K01DA039299 (1), K01DA052673 (1), K23DA020681 (1), P30CA012197 (1), P50DA009236 (1), R01AG047979 (1), R01DA016718 (1), R01DA016759 (1)